Jason C. Jones - 04 Dec 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role: Senior VP Product Development
Signature: /s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol: EKSO
Transactions as of: 04 Dec 2022
Transactions value $: $0
Form type: 4
Filing time: 06 Dec 2022, 18:03:17 UTC
Previous filing: 17 Nov 2022
Next filing: 17 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EKSO	Common Stock	Award	$0	+17K	+13.61%	$0.00	142K	04 Dec 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The grant of restricted stock units ("RSUs") was approved by the Issuer's Compensation Committee of the Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. One-third of the RSUs shall vest on each of the first three anniversaries of the grant date, subject to the Reporting Person continuing to be a Service Provider (as defined under the Plan) through such date.
F2	Includes 43,680 unvested RSUs.

Content

The grant of restricted stock units ("RSUs") was approved by the Issuer's Compensation Committee of the Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. One-third of the RSUs shall vest on each of the first three anniversaries of the grant date, subject to the Reporting Person continuing to be a Service Provider (as defined under the Plan) through such date.

Includes 43,680 unvested RSUs.